95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.89%
Positive revenue growth while RGLD is negative. John Neff might see a notable competitive edge here.
-3.63%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-4.14%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-4.14%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-3.92%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-4.76%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-2.44%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.06%
Slight or no buybacks while RGLD is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.12%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
5.56%
Positive OCF growth while RGLD is negative. John Neff would see this as a clear operational advantage vs. the competitor.
5.81%
Positive FCF growth while RGLD is negative. John Neff would see a strong competitive edge in net cash generation.
513.84%
10Y revenue/share CAGR 1.25-1.5x RGLD's 444.38%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
204.35%
5Y revenue/share CAGR above 1.5x RGLD's 75.30%. David Dodd would look for consistent product or market expansions fueling outperformance.
309.78%
3Y revenue/share CAGR above 1.5x RGLD's 75.46%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
4244.28%
10Y OCF/share CAGR above 1.5x RGLD's 410.77%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
289.09%
5Y OCF/share CAGR 1.25-1.5x RGLD's 194.73%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
450.63%
3Y OCF/share CAGR above 1.5x RGLD's 195.36%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
13671.58%
Positive 10Y CAGR while RGLD is negative. John Neff might see a substantial advantage in bottom-line trajectory.
287.69%
5Y net income/share CAGR above 1.5x RGLD's 51.56%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
546.07%
3Y net income/share CAGR above 1.5x RGLD's 89.46%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
2996.55%
10Y equity/share CAGR 1.25-1.5x RGLD's 2021.27%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
139.38%
5Y equity/share CAGR is in line with RGLD's 141.37%. Walter Schloss would see parallel mid-term profitability and retention policies.
83.50%
3Y equity/share CAGR 1.25-1.5x RGLD's 59.48%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.66%
Firm’s AR is declining while RGLD shows 4.68%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
1.70%
Asset growth well under 50% of RGLD's 12.68%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.90%
50-75% of RGLD's 4.30%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-9.99%
We’re deleveraging while RGLD stands at 156.34%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-1.99%
We cut SG&A while RGLD invests at 3.97%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.